Regulations/Legal

Latest Issue of OR Manager
September 2025
Home Regulations/Legal

AI agents sweep healthcare, promising speed and efficiency

Editor's Note Various digital health companies are racing to introduce a new wave of artificial intelligence (AI) tools—often called AI agents—designed to handle labor-intensive tasks in healthcare with unprecedented speed. These specialized tools aim to manage everything from verifying insurance benefits and clarifying pre-procedure details for patients to aiding in…

Read More

By: Tarsilla Moura
March 24, 2025
Share

Bipartisan bill would expand presidential trade authority over medical goods

Editor's Note The bipartisan Medical Supply Chain Resiliency Act would grant the president expanded authority to negotiate trade deals and modify tariffs on medical goods, according to a March 14 report from Fierce Healthcare. The bill, backed by pharmaceutical and healthcare industry groups, aims to strengthen the US medical supply…

Read More

By: Matt Danford
March 20, 2025
Share

Legislation proposes granting CRNA practice authority to expand anesthesia access for veterans

Editor's Note Legislation introduced in the US House of Representatives seeks to expand access to anesthesia care for veterans by granting Certified Registered Nurse Anesthetists (CRNAs) full practice authority within the Veterans Health Administration (VHA). The Ensuring Veterans Timely Access to Anesthesia Care Act of 2025 is sponsored by Representatives…

Read More

By: Matt Danford
March 20, 2025
Share

FDA announces Class 1 recall for implantable ports

Editor's Note The US Food and Drug Administration (FDA) has deemed Smiths Medical’s recall of Proport Plastic Implantable Ports a Class 1, the most severe designation indicating serious risk of injury or death. The devices are designed for repeated venous access for injections, infusions, and/or blood samples. According to the…

Read More

By: Matt Danford
March 20, 2025
Share

Sponsored Message

FDA designates Class 1 recall for embolization devices

Editor's Note Endovascular devices used to block aneurysm blood flow are the subject of the latest recall to be designated Class 1—the most severe designation indicating serious risk of injury or death—by the US Food and Drug Administration (FDA). As detailed in the agency’s March 18 announcement, Medtronic Neurovascular is…

Read More

By: Matt Danford
March 19, 2025
Share

AI reshapes healthcare leadership

Editor's Note Chief data officer (CDO) is a fast-growing C-suite role across the economy, with the notable exception of healthcare. The reasons why might be surprising: these roles have already been filled. Rather than growing, they are evolving. That’s the primary message of a March 4 report in Becker’s Hospital…

Read More

By: Matt Danford
March 19, 2025
Share

Sponsored Message

States seek restraints on healthcare private equity

Editor's Note Multiple states seek to limit corporate influence in medicine by instituting additional checks on private equity-driven healthcare mergers, according to a March 17 report in Axios. Referencing multiple state-specific reports, the article summarizes specific efforts in Massachusetts, where a new law expands oversight of transactions; Maine, where a…

Read More

By: Matt Danford
March 17, 2025
Share

GLP-1 drugs reshape surgery demand, threaten hospital revenue

Editor's Note The widespread adoption of GLP-1 weight-loss medications like Ozempic and Wegovy could put revenue at risk across multiple service lines, according to a March 11 article in Becker’s Hospital Review. As a result, hospitals and ambulatory surgery centers (ASCs) face critical questions about how to adapt. The article…

Read More

By: Matt Danford
March 14, 2025
Share

UnitedHealth’s dominant growth forges ahead amid intensifying antitrust scrutiny

Editor's Note In addition to the uptick in acquiring outpatient facilities since 2023, UnitedHealth Group quietly acquired or created more than 250 subsidiaries last year, expanding its already vast network of services comprising a major health insurer, physician practices, a pharmacy benefit manager, and various other healthcare ventures, STAT March…

Read More

By: Tarsilla Moura
March 12, 2025
Share

Analysis: How the new US malpractice standard puts evidence-based ‘reasonable care’ over customary practice

Editor's Note A February 26 letter in JAMA Network reported a revised legal standard for medical negligence in the US, shifting from traditional reliance on customary practice toward a more patient-centered, evidence-based definition of “reasonable care.” The American Law Institute (ALI) updated its framework in 2024, retaining elements of prevailing…

Read More

By: Tarsilla Moura
March 12, 2025
Share

Join our community

Learn More
Video Spotlight
Live chat by BoldChat